Published in Adv Neurol on January 01, 2003
DJ-1 protects against dopamine toxicity. J Neural Transm (Vienna) (2008) 1.11
Cellular interplay between neurons and glia: toward a comprehensive mechanism for excitotoxic neuronal loss in neurodegeneration. Cellscience (2007) 0.92
Preferential Extracellular Generation of the Active Parkinsonian Toxin MPP(+) by Transporter-Independent Export of the Intermediate MPDP(.). Antioxid Redox Signal (2015) 0.75
Differences in vulnerability of neurons and astrocytes to heme oxygenase-1 modulation: Implications for mitochondrial ferritin. Sci Rep (2016) 0.75
A double-blind, delayed-start trial of rasagiline in Parkinson's disease. N Engl J Med (2009) 5.81
VPS35 mutations in Parkinson disease. Am J Hum Genet (2011) 4.16
Levodopa in the treatment of Parkinson's disease: current controversies. Mov Disord (2004) 2.90
The natural history of multiple system atrophy: a prospective European cohort study. Lancet Neurol (2013) 2.65
The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy. J Neurol (2004) 2.40
Validation of the freezing of gait questionnaire in patients with Parkinson's disease. Mov Disord (2009) 1.90
Antioxidant therapy in acute central nervous system injury: current state. Pharmacol Rev (2002) 1.76
Bax ablation protects against myocardial ischemia-reperfusion injury in transgenic mice. Am J Physiol Heart Circ Physiol (2003) 1.75
Handedness as a predictor of side of onset of Parkinson's disease. Parkinsonism Relat Disord (2008) 1.74
A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes. Lancet Neurol (2011) 1.68
Lesions outside the CNS in Parkinson's disease. Mov Disord (2009) 1.55
The mystery of motor asymmetry in Parkinson's disease. Lancet Neurol (2006) 1.55
Erythropoietin delays disease onset in an amyotrophic lateral sclerosis model. Exp Neurol (2006) 1.47
The "dying-back" phenomenon of motor neurons in ALS. J Mol Neurosci (2010) 1.45
The hyperperfusion syndrome: an under-recognized complication of carotid endarterectomy. Isr Med Assoc J (2004) 1.40
18F-ML-10, a PET tracer for apoptosis: first human study. J Nucl Med (2011) 1.26
Mutant and wild-type alpha-synuclein interact with mitochondrial cytochrome C oxidase. J Mol Neurosci (2002) 1.25
The etiopathogenesis of Parkinson disease and suggestions for future research. Part I. J Neuropathol Exp Neurol (2007) 1.21
Clinicogenetic study of mutations in LRRK2 exon 41 in Parkinson's disease patients from 18 countries. Mov Disord (2006) 1.20
From the Gla domain to a novel small-molecule detector of apoptosis. Cell Res (2009) 1.19
Intravitreal injections of neurotrophic factors secreting mesenchymal stem cells are neuroprotective in rat eyes following optic nerve transection. Invest Ophthalmol Vis Sci (2010) 1.18
Human mesenchymal stem cells express neural genes, suggesting a neural predisposition. Stem Cells Dev (2006) 1.17
[123I]-FP/CIT SPECT imaging for distinguishing drug-induced parkinsonism from Parkinson's disease. Mov Disord (2006) 1.14
Immunosuppressive role of semaphorin-3A on T cell proliferation is mediated by inhibition of actin cytoskeleton reorganization. Eur J Immunol (2006) 1.14
Bone-marrow-derived mesenchymal stem cell therapy for neurodegenerative diseases. Expert Opin Biol Ther (2009) 1.13
DJ-1 protects against dopamine toxicity. J Neural Transm (Vienna) (2008) 1.11
Oxidative insults induce DJ-1 upregulation and redistribution: implications for neuroprotection. Neurotoxicology (2008) 1.07
Introducing transcription factors to multipotent mesenchymal stem cells: making transdifferentiation possible. Stem Cells (2009) 1.07
Apoptosis and Parkinson's disease. Prog Neuropsychopharmacol Biol Psychiatry (2003) 1.06
Molecular imaging of cell death in vivo by a novel small molecule probe. Apoptosis (2006) 1.05
Protective effects of neurotrophic factor-secreting cells in a 6-OHDA rat model of Parkinson disease. Stem Cells Dev (2009) 1.03
Assessment of response of brain metastases to radiotherapy by PET imaging of apoptosis with ¹⁸F-ML-10. Eur J Nucl Med Mol Imaging (2012) 1.03
Induction of human mesenchymal stem cells into dopamine-producing cells with different differentiation protocols. Stem Cells Dev (2008) 1.01
Molecular mechanisms of selective dopaminergic neuronal death in Parkinson's disease. Trends Mol Med (2003) 1.00
A low molecular weight copper chelator crosses the blood-brain barrier and attenuates experimental autoimmune encephalomyelitis. J Neurochem (2004) 1.00
Small-molecule biomarkers for clinical PET imaging of apoptosis. J Nucl Med (2010) 0.99
Riluzole suppresses experimental autoimmune encephalomyelitis: implications for the treatment of multiple sclerosis. Brain Res (2003) 0.98
Mesenchymal stem cells stimulate endogenous neurogenesis in the subventricular zone of adult mice. Stem Cell Rev (2011) 0.98
Therapeutic potential of neurotrophic factors in neurodegenerative diseases. BioDrugs (2005) 0.97
Spinal cord mRNA profile in patients with ALS: comparison with transgenic mice expressing the human SOD-1 mutant. J Mol Neurosci (2008) 0.97
Differentiated mesenchymal stem cells for sciatic nerve injury. Stem Cell Rev (2011) 0.96
Wnt signaling enhances neurogenesis and improves neurological function after focal ischemic injury. PLoS One (2012) 0.96
Antioxidant treatment in Alzheimer's disease: current state. J Mol Neurosci (2003) 0.96
Neurogenesis in the aged and neurodegenerative brain. Apoptosis (2010) 0.96
Anti-semaphorin 3A antibodies rescue retinal ganglion cells from cell death following optic nerve axotomy. J Biol Chem (2002) 0.96
Lentiviral delivery of LMX1a enhances dopaminergic phenotype in differentiated human bone marrow mesenchymal stem cells. Stem Cells Dev (2009) 0.95
Targeting cell death in vivo in experimental traumatic brain injury by a novel molecular probe. J Neurotrauma (2008) 0.95
DJ-1 changes in G93A-SOD1 transgenic mice: implications for oxidative stress in ALS. J Mol Neurosci (2008) 0.94
Molecular imaging of neurovascular cell death in experimental cerebral stroke by PET. J Nucl Med (2008) 0.94
123I-FP-CIT SPECT imaging of dopamine transporters in patients with cerebrovascular disease and clinical diagnosis of vascular parkinsonism. J Nucl Med (2004) 0.93
Monitoring of tumor response to chemotherapy in vivo by a novel small-molecule detector of apoptosis. Apoptosis (2009) 0.93
Intracerebroventricular transplantation of human mesenchymal stem cells induced to secrete neurotrophic factors attenuates clinical symptoms in a mouse model of multiple sclerosis. J Mol Neurosci (2009) 0.93
Oxidative stress, induced by 6-hydroxydopamine, reduces proteasome activities in PC12 cells: implications for the pathogenesis of Parkinson's disease. J Mol Neurosci (2004) 0.92
Induction of adult human bone marrow mesenchymal stromal cells into functional astrocyte-like cells: potential for restorative treatment in Parkinson's disease. J Mol Neurosci (2009) 0.92
Transplantation of placenta-derived mesenchymal stem cells in the EAE mouse model of MS. J Mol Neurosci (2012) 0.92
A peptide antagonist of CD28 signaling attenuates toxic shock and necrotizing soft-tissue infection induced by Streptococcus pyogenes. J Infect Dis (2013) 0.91
Trial designs used to study neuroprotective therapy in Parkinson's disease. Mov Disord (2012) 0.91
Migration of neurotrophic factors-secreting mesenchymal stem cells toward a quinolinic acid lesion as viewed by magnetic resonance imaging. Stem Cells (2008) 0.91
Axonal damage is reduced following glatiramer acetate treatment in C57/bl mice with chronic-induced experimental autoimmune encephalomyelitis. Neurosci Res (2003) 0.90
ApoSense: a novel technology for functional molecular imaging of cell death in models of acute renal tubular necrosis. Eur J Nucl Med Mol Imaging (2005) 0.89